KYNB Kyntra Bio, Inc.
$3.44
Kyntra Bio, Inc. (KYNB) Earnings News
Earnings press releases, previews and reviews for Kyntra Bio, Inc. (KYNB), newest first. Our most recent is preview: Kyntra Bio Heads Into Q3 With Stock Halved and a Prostate Cancer Interim Readout Looming.
Sunday
November 15, 2026
2:41 PM ET
Kyntra Bio Heads Into Q3 With Stock Halved and a Prostate Cancer Interim Readout Looming
Earnings Whispers · Preview
Friday
November 13, 2026
8:30 AM ET
Kyntra Bio to Report Third Quarter 2026 Financial Results
Thursday
August 13, 2026
4:02 PM ET
Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Thursday
August 6, 2026
9:00 AM ET
Kyntra Bio to Report Second Quarter 2026 Financial Results